Mięsak
Diagnostyka i diagnoza

Mięsaki to rzadkie, złośliwe nowotwory tkanek łącznych, stanowiące około 1% wszystkich nowotworów u dorosłych i 15% u dzieci, z roczną zachorowalnością w USA na poziomie około 16 000 przypadków (4000 mięsaków kości i 13 000 tkanek miękkich). Diagnostyka jest wyzwaniem ze względu na heterogeniczność i niespecyficzne objawy, takie jak bezbolesny guz powiększający się powyżej 5 cm, głęboko położony względem powięzi, czasem z towarzyszącym bólem. Kluczowe jest wykonanie badań obrazowych przed biopsją, z preferencją MRI dla kończyn, CT dla jamy brzusznej i klatki piersiowej, RTG przy podejrzeniu mięsaków kości oraz PET/CT do oceny aktywności metabolicznej i przerzutów. Biopsja gruboigłowa jest metodą z wyboru, wykonywaną w ośrodkach specjalistycznych, z wykorzystaniem technik obrazowych do precyzyjnego pobrania materiału. Badania histopatologiczne i immunohistochemiczne pozwalają na określenie typu i stopnia złośliwości (grade 1-3), co ma istotne znaczenie prognostyczne.

Diagnostyka Mięsaka

Mięsak (sarcoma) to rzadki, złośliwy nowotwór wywodzący się z tkanek łącznych, takich jak kości, chrząstki, mięśnie, tkanki tłuszczowe, naczynia krwionośne, nerwy i tkanki otaczające stawy. Mięsaki stanowią zaledwie około 1% wszystkich diagnoz nowotworów u dorosłych i około 15% diagnoz nowotworów u dzieci. W Stanach Zjednoczonych rocznie diagnozuje się około 16000 przypadków mięsaków (około 4000 mięsaków kości i około 13000 mięsaków tkanek miękkich). Ze względu na rzadkość występowania i heterogeniczny charakter, diagnostyka mięsaków jest szczególnie wymagająca i kluczowa dla skutecznego leczenia12.

Objawy kliniczne i wstępna ocena

Objawy mięsaka są często niespecyficzne, co może utrudniać wczesne rozpoznanie. Najczęstszym objawem jest bezbolesny guz lub obrzęk, który stopniowo się powiększa. Objawy alarmujące, które powinny wzbudzić podejrzenie mięsaka, obejmują:12

  • Guz lub obrzęk, który powiększa się1
  • Wielkość guza przekraczająca 5 cm1
  • Głębokie umiejscowienie względem powięzi2
  • Ból (choć nie zawsze występuje)1

Wstępna ocena pacjenta powinna obejmować dokładny wywiad medyczny oraz badanie fizykalne. Lekarz powinien zebrać informacje na temat historii zdrowotnej pacjenta, występowania objawów, czynników ryzyka oraz historii rodzinnej chorób nowotworowych12.

Badania obrazowe

Badania obrazowe odgrywają kluczową rolę w diagnostyce mięsaka. Zalecane jest przeprowadzenie badań przed biopsją, aby uniknąć krwawienia i zmian zapalnych, które mogłyby zniekształcić charakterystykę i zasięg guza1.

Najczęściej stosowane metody obrazowania w diagnostyce mięsaka to:12

  • Rezonans magnetyczny (MRI) – preferowana metoda do badania podejrzanych zmian w kończynach; dostarcza szczegółowych informacji o wielkości guza, jego granicach i stosunku do sąsiadujących struktur1
  • Tomografia komputerowa (CT) – szczególnie przydatna do oceny zmian w jamie brzusznej, przestrzeni zaotrzewnowej i klatce piersiowej; pomaga również w określeniu, czy nowotwór rozprzestrzenił się do innych części ciała2
  • RTG – może być pierwszym badaniem obrazowym, zwłaszcza przy podejrzeniu mięsaka kości1
  • PET/CT – przydatny do oceny aktywności metabolicznej guza i potencjalnych przerzutów1
  • Scyntygrafia kości – używana do sprawdzenia, czy mięsak tkanek miękkich rozprzestrzenił się do kości1
  • USG – może być stosowane do wstępnej oceny masy lub do kierowania biopsji2

Biopsja

Biopsja jest kluczowym elementem diagnostyki mięsaka i jedynym pewnym sposobem potwierdzenia rozpoznania. Powinna być wykonywana w sposób, który nie utrudni przyszłego leczenia chirurgicznego1. Istnieje kilka rodzajów biopsji:12

  • Biopsja gruboigłowa (core needle biopsy) – obecnie zalecana jako metoda z wyboru w diagnostyce mięsaka; jest minimalnie inwazyjna i nie ogranicza późniejszych interwencji chirurgicznych1
  • Biopsja cienkoigłowa (FNA) – może być stosowana w niektórych przypadkach, ale często dostarcza mniej materiału do badań1
  • Biopsja chirurgiczna – może być konieczna, jeśli biopsja igłowa nie dostarcza wystarczającej ilości materiału do rozpoznania1

Biopsja powinna być wykonywana przez specjalistów z doświadczeniem w leczeniu mięsaków, najlepiej w ośrodku specjalizującym się w diagnostyce i leczeniu tych nowotworów1. Zastosowanie technik radiologicznych do kierowania biopsją (USG, CT) znacznie poprawiło dokładność procedury diagnostycznej1.

Badania laboratoryjne

Badania krwi nie są specyficzne dla diagnostyki mięsaka, ale mogą być pomocne w ogólnej ocenie stanu pacjenta oraz przed biopsją1:

Zaawansowane metody diagnostyczne

Badania histopatologiczne i immunohistochemiczne

Po pobraniu próbki podczas biopsji, materiał jest analizowany przez patologa z doświadczeniem w diagnostyce mięsaków. Badanie histopatologiczne obejmuje ocenę mikroskopową komórek nowotworowych, co pozwala określić typ i stopień złośliwości (grade) mięsaka1.

Badania immunohistochemiczne są często wykonywane jako uzupełnienie oceny morfologicznej w celu określenia typu komórek/tkanki pochodzenia i rozróżnienia między konkretnymi podtypami mięsaka. Polega to na barwieniu próbki tkanki specyficznymi przeciwciałami, które wiążą się z określonymi białkami na powierzchni komórek nowotworowych1.

Stopień złośliwości (grade) jest ważnym czynnikiem prognostycznym i może wpływać na decyzje dotyczące leczenia. Mięsaki dzieli się na trzy stopnie złośliwości (1 do 3), gdzie wyższy stopień oznacza bardziej agresywny nowotwór o większym prawdopodobieństwie rozprzestrzeniania się12.

Badania genetyczne i molekularne

Badania genetyczne i molekularne stają się coraz ważniejsze w diagnostyce mięsaków. Mogą one pomóc w potwierdzeniu diagnozy, klasyfikacji podtypu mięsaka oraz w doborze najskuteczniejszego leczenia1.

Najczęściej stosowane techniki badań genetycznych w diagnostyce mięsaków to:12

  • Fluorescencyjna hybrydyzacja in situ (FISH) – używana do identyfikacji specyficznych translokacji chromosomowych charakterystycznych dla określonych podtypów mięsaka1
  • Cytogenetyka – analizuje zmiany w chromosomach1
  • Badania molekularne – wykrywają specyficzne mutacje genowe, fuzje genów i inne zmiany molekularne1
  • Sekwencjonowanie nowej generacji (NGS) – umożliwia kompleksową analizę genomu komórek nowotworowych1

Wiele podtypów mięsaka charakteryzuje się specyficznymi zmianami cytogenetycznymi i molekularnymi, w tym amplifikacjami, delecjami, nawracającymi translokacjami lub mutacjami punktowymi. Identyfikacja tych zmian może być kluczowa dla dokładnej diagnozy1.

W niektórych przypadkach możliwe jest również przeprowadzenie testów genetycznych w kierunku zespołów genetycznych związanych z podwyższonym ryzykiem rozwoju mięsaka, takich jak zespół Li-Fraumeni, dziedziczne siatkówczaki, zespół neurofibromatozy czy zespół Wernera1.

Znaczenie specjalistycznych ośrodków w diagnostyce mięsaków

Ze względu na rzadkość występowania i złożoność diagnostyki mięsaków, zaleca się, aby pacjenci z podejrzeniem mięsaka byli kierowani do specjalistycznych ośrodków z doświadczeniem w leczeniu tych nowotworów12.

Korzyści z diagnostyki w specjalistycznym ośrodku obejmują:12

  • Dostęp do patologów specjalizujących się w diagnostyce mięsaków1
  • Wyższy poziom dokładności diagnostycznej – w około 15% przypadków diagnoza zmienia się po weryfikacji przez eksperta1
  • Możliwość przeprowadzenia kompleksowych badań genetycznych i molekularnych2
  • Doświadczenie w planowaniu i przeprowadzaniu biopsji w sposób minimalizujący ryzyko rozprzestrzeniania się nowotworu1
  • Multidyscyplinarne podejście do diagnostyki i leczenia1

Problemy w diagnostyce mięsaków

Diagnostyka mięsaków może być wyzwaniem z kilku powodów:12

  • Rzadkość występowania – lekarze pierwszego kontaktu rzadko spotykają się z tymi nowotworami1
  • Niespecyficzne objawy – mogą być mylone z łagodnymi zmianami lub innymi schorzeniami1
  • Heterogeniczny charakter – istnieje ponad 50 różnych podtypów histologicznych mięsaków1
  • Błędna interpretacja badań obrazowych – mięsaki mogą być pomijane na skanach lub błędnie diagnozowane1
  • Nieodpowiednie wykonanie biopsji – niewłaściwa biopsja może prowadzić do rozprzestrzeniania się nowotworu1

Opóźnienia w diagnozie mogą prowadzić do wzrostu guza, zwiększonego ryzyka przerzutów, zwiększonego ryzyka amputacji zamiast operacji oszczędzającej kończynę oraz mogą mieć wpływ na możliwości zachowania płodności u pacjenta1.

Ocena zaawansowania mięsaka

Po potwierdzeniu rozpoznania mięsaka, konieczne jest określenie stopnia zaawansowania (staging) nowotworu, co pomaga w planowaniu leczenia i ocenie rokowania1.

Najczęściej stosowanym systemem oceny zaawansowania mięsaka jest system TNM (Tumor-Node-Metastasis) Amerykańskiego Wspólnego Komitetu ds. Raka (AJCC)1:

  • T (Tumor) – określa wielkość guza pierwotnego1
  • N (Node) – określa, czy nowotwór rozprzestrzenił się do węzłów chłonnych1
  • M (Metastasis) – określa, czy nowotwór rozprzestrzenił się do odległych części ciała1
  • G (Grade) – ocenia stopień złośliwości nowotworu na podstawie wyglądu komórek pod mikroskopem1

Na podstawie tych czynników mięsak jest klasyfikowany do jednego z czterech stadiów (I do IV), gdzie stadium I oznacza najmniej zaawansowany nowotwór, a stadium IV – najbardziej zaawansowany1.

Znaczenie wczesnej i dokładnej diagnostyki

Dokładna i wczesna diagnostyka mięsaka jest kluczowa dla skutecznego leczenia i lepszego rokowania12:

  • Mniejszy rozmiar guza w momencie diagnozy (≤ 5 cm) wiąże się z lepszym rokowaniem1
  • Wczesna diagnoza umożliwia mniej inwazyjne zabiegi chirurgiczne i zwiększa szanse na zachowanie kończyny1
  • Zmniejsza ryzyko przerzutów1
  • Pozwala na wcześniejsze rozpoczęcie leczenia, co może poprawić wyniki1

Opóźnienia w diagnostyce są częstsze w przypadku rzadkich nowotworów, takich jak mięsak. Pacjenci z mięsakiem częściej zgłaszają wielokrotne wizyty u lekarza podstawowej opieki zdrowotnej i są mniej zadowoleni z czasu oczekiwania na wizytę u specjalisty w porównaniu z pacjentami z częściej występującymi nowotworami1.

Podsumowanie procesu diagnostycznego

Proces diagnostyczny mięsaka obejmuje kilka kluczowych etapów:12

  1. Ocena kliniczna – wywiad medyczny i badanie fizykalne1
  2. Badania obrazowe – MRI, CT, PET/CT, RTG, USG1
  3. Biopsja – pobranie próbki tkanki do badania1
  4. Badania histopatologiczne i immunohistochemiczne – określenie typu i stopnia złośliwości mięsaka1
  5. Badania genetyczne i molekularne – identyfikacja specyficznych zmian genetycznych1
  6. Ocena zaawansowania – określenie stadium nowotworu1

Diagnostyka mięsaka wymaga współpracy multidyscyplinarnego zespołu, w skład którego wchodzą radiolodzy, patologowie, chirurdzy onkologiczni, onkolodzy kliniczni i inni specjaliści1.

Po zakończeniu procesu diagnostycznego, multidyscyplinarny zespół może opracować indywidualny plan leczenia, który może obejmować chirurgię, radioterapię, chemioterapię i inne metody terapeutyczne, w zależności od typu mięsaka, jego lokalizacji, stopnia zaawansowania i innych czynników12.

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 12.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Sarcoma: What it Is, Symptoms & Treatment
    https://my.clevelandclinic.org/health/diseases/17934-sarcoma
    A sarcoma is a rare type of malignant (cancerous) tumor that develops in bone and connective tissue, such as fat, muscle, blood vessels, nerves and the tissue that surrounds bones and joints. […] Sarcomas are rare, making up only 1% of all adult cancer diagnoses and about 15% of childhood cancer diagnoses. Approximately 16,000 sarcomas are diagnosed in the United States each year (around 4,000 bone sarcomas and approximately 13,000 soft tissue sarcomas). […] Sarcoma affects both children and adults. Generally, soft tissue sarcoma occurs more frequently in adults. Bone sarcoma diagnoses occur more often in children, teens and people older than 65 years. Bone sarcoma occurs more frequently in males and people who are Black or Hispanic. […] Your healthcare provider will begin with a thorough history and physical examination. They may perform special tests on a tissue sample obtained from a biopsy to diagnose the exact type of sarcoma you have.
  • #1 Diagnosis and treatment of soft-tissue sarcomas of the extremities and trunk
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5702952/
    The relatively low incidence and often atypical clinical presentation of soft-tissue sarcomas (STS) impedes early and adequate diagnosis. Patients may report on recently enlarged soft-tissue swellings, infrequently complain of painful lesions, or even have no symptoms at all. […] A thorough diagnostic work-up is essential in order to distinguish between benign soft-tissue tumours and STSs. Patient history, clinical features and radiological findings all help in assessing the underlying pathology. Worrying features such as recent increase in size, deep location relative to the fascia, a tumour exceeding 4 cm in size, and invasive growth patterns seen on imaging should prompt verification by biopsy. […] The diagnostic pathway should always start with a thorough documentation of the patients history. Lumps that have not changed in size or shape over the years are most likely benign, whereas recently noticed, constantly-enlarging swellings should urge caution.
  • #1 Soft tissue sarcoma: Recognizing a rare disease | Cleveland Clinic Journal of Medicine
    https://www.ccjm.org/content/89/2/73
    A smaller tumor at diagnosis ( 5 cm) is associated with better prognosis. […] Increasing size is the best individual indicator of a greater risk of malignancy. […] According to guidelines, a patient with a concerning lump or mass that is increasing in size, larger than 5 cm, in the deep fascia, and painful should be referred immediately to a sarcoma center for further evaluation, even if the risk of malignancy is only 3% to 4%. […] A high degree of suspicion for STS based on the biopsy results should trigger prompt referral to a sarcoma center for triple assessment of clinical history, imaging, and biopsy, all of which should be done on the same day. […] Effective management of patients with suspected STS requires practitioners to be aware of the signs and symptoms and to know the appropriate testing procedures.
  • #1 Diagnosis and treatment of soft-tissue sarcomas of the extremities and trunk
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5702952/
    Pain assessment is important in every physician-patient consultation. In cases of STS, however, pain is a rather poor discriminator between benign and malignant lesions. […] As the majority of STSs are located deep to the fascia, every deeply-situated tumour should be considered malignant until proven otherwise. […] A simple rule of thumb is that every growing soft-tissue mass larger than a golf ball (equivalent to about 4 cm) that has been recently noticed should be suspected of being a sarcoma. […] The chief objectives of imaging are to confirm clinical findings by detecting a soft-tissue mass, to estimate its size, tissue quality and relation to adjacent structures in detail, and to aid planning of the further course of action. […] Magnetic resonance imaging (MRI) is the method of choice to evaluate soft-tissue tumours and to distinguish benign from malignant lesions, especially if prior clinical findings and imaging were inconclusive.
  • #1 Clinical practice guidelines for the diagnosis and treatment of patients with soft tissue sarcoma by the Spanish group for research in sarcomas (GEIS)
    https://pmc.ncbi.nlm.nih.gov/articles/PMC4706580/
    Soft tissue sarcomas (STS) constitute an uncommon and heterogeneous group of tumours, which require a complex and specialized multidisciplinary management. The diagnostic approach should include imaging studies and core needle biopsy performed prior to undertaking surgery. […] In the document, each practical recommendation is accompanied by level of evidence and grade of recommendation on the basis of the available data. […] The symptoms of presentation of benign and malignant soft tissue tumours can frequently overlap, but there are clinical warning signs that may help to distinguish between both situations: tumour size 5 cm and recent increase in tumour size and depth location or pain. […] It is recommended that patients in which a STS is suspected should be referred to a specialized center before the biopsy is performed because complications and mistakes are more frequent in non specialized ones.
  • #1 Diagnosis of soft tissue sarcoma | Canadian Cancer Society
    https://cancer.ca/en/cancer-information/cancer-types/soft-tissue-sarcoma/diagnosis
    Diagnosis is the process of finding out the cause of a health problem. Diagnosing soft tissue sarcoma can begin with a visit to a doctor, often a specialist. Your doctor will ask you about any symptoms you have and may do a physical exam. The doctor may order tests to check for soft tissue sarcoma or other health problems. But sometimes soft tissue sarcomas are found by chance (incidentally) while checking for a different health problem. […] The following tests are usually used to rule out or diagnose soft tissue sarcoma. Many of the same tests used to diagnose cancer are used to find out how far the cancer has spread (the extent of the cancer). Your doctor may also order other tests to check your general health and to help plan your treatment. […] A physical exam allows your doctor to look for any signs of soft tissue sarcoma. During a physical exam, your doctor may: examine any lumps on your body, including checking their size and shape and how they feel; check how certain parts of your body are moving, such as your arms and legs, and if there is any weakness; examine the lungs; feel the abdomen for an enlarged liver or abnormalities.
  • #1 Clinical practice guidelines for the diagnosis and treatment of patients with soft tissue sarcoma by the Spanish group for research in sarcomas (GEIS)
    https://pmc.ncbi.nlm.nih.gov/articles/PMC4706580/
    Magnetic resonance imaging (MRI) is the modality of choice in the diagnosis and local staging of soft tissue sarcomas. […] Local tumour staging should be performed prior to the biopsy to prevent bleeding and inflammatory changes caused by the biopsy that can distort the characteristics and extent of the tumour on MRI. […] Percutaneous core needle biopsy (CNB), also known as tru-cut biopsy, is currently recommended for STS diagnosis, because it is minimally invasive and will not limit subsequent surgical interventions. […] The use of radiological techniques to guide the CNB, mainly ultrasound and CT, has substantially improved diagnostic procedures. […] Appropriate clinical information should be available for a correct interpretation of the initial biopsy. […] In general, the core needle biopsy (tru-cut) is the diagnostic method of choice.
  • #1 Diagnosis of soft tissue sarcoma | Canadian Cancer Society
    https://cancer.ca/en/cancer-information/cancer-types/soft-tissue-sarcoma/diagnosis
    A complete blood count (CBC) measures the number and quality of white blood cells, red blood cells and platelets. A CBC is done to check your general health, often before a biopsy. […] Blood clotting (coagulation) tests check if your blood is clotting properly. Prothrombin time (PT), partial thromboplastin time (PTT) and international normalized ratio (INR) are common blood clotting tests. They are usually checked before a biopsy is done. […] An MRI is commonly used to examine a lump that doctors think may be a soft tissue sarcoma. It is often the first imaging test done for lumps in the arms or legs. An MRI can check the size of a tumour, what tissues and areas are nearby and if it has spread to other parts of the body. […] A CT scan is commonly used to examine a lump in a specific area, including checking its size and finding out what tissues and areas are nearby. It is often used to check the abdomen, back of the abdomen (retroperitoneum) and chest. If soft tissue sarcoma is diagnosed, a CT scan can be used to check if the cancer has spread to other parts of the body.
  • #1 Diagnosing Sarcoma in Children | NYU Langone Health
    https://nyulangone.org/conditions/sarcoma-in-children/diagnosis
    At the Stephen D. Hassenfeld Childrens Center for Cancer and Blood Disorders, part of Hassenfeld Childrens Hospital at NYU Langone, our experts diagnose and treat childhood sarcomas, cancerous tumors that occur in bone or soft tissue, which connects and supports bones and organs. […] To diagnose a sarcoma, a doctor takes a medical history and performs a physical examination. Our pediatric oncologists may perform other tests to diagnose the type of sarcoma and determine its severity. […] Doctors draw blood and send it to a lab to be tested for levels of red blood cells, which carry oxygen in the blood; white blood cells, which fight infection; and platelets, which help the blood clot. […] X-ray images of the bones are the first step in determining if cancer is present. Sarcomas are often recognizable on X-ray images, so doctors may use this test if they suspect a tumor is present.
  • #1 Soft Tissue Sarcoma Diagnosis and Detection
    https://www.cancercenter.com/cancer-types/soft-tissue-sarcoma/diagnosis-and-detection
    PET scans are very sensitive but don’t show much detail, they often are performed in combination with a CT scan (called PET/CT). […] Ultrasound scans may be used to provide information about a tumor or surrounding tissues and organs, and to precisely locate the position of a tumor in order to guide a needle biopsy. […] The lungs are a common location for soft tissue sarcomas to metastasize (spread). Therefore, X-rays of the chest may be taken to see if the cancer has spread to the lungs. […] Laparoscopic ultrasound and laparoscopic biopsies may also be performed by the surgeon to diagnose and stage soft tissue sarcoma. For tumors located within the abdomen, a laparoscopic procedure is sometimes used to diagnose or stage the extent of disease.
  • #1 Diagnosis of soft tissue sarcoma | Canadian Cancer Society
    https://cancer.ca/en/cancer-information/cancer-types/soft-tissue-sarcoma/diagnosis
    During a biopsy, the doctor removes tissues or cells from the body so they can be tested in a lab. A report from the pathologist will show whether or not cancer cells are found in the sample. If cancer is diagnosed, the report will also show the type of cancer and grade of the tumour. […] A bone scan uses bone-seeking radioactive materials called radiopharmaceuticals and a computer to create a picture of the bones. It is used to check if the soft tissue sarcoma has spread to the bone.
  • #1 Soft tissue sarcoma – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/soft-tissue-sarcoma/diagnosis-treatment/drc-20377730
    Tests and procedures used to diagnose soft tissue sarcoma include imaging tests and procedures to remove a sample of cells for testing. […] Imaging tests create pictures of the inside of the body. They might help show the size and location of the soft tissue sarcoma. […] A procedure to remove some cells for testing is called a biopsy. A biopsy for soft tissue sarcoma needs to be done in a way that won’t cause problems with future surgery. […] The biopsy sample goes to a lab for testing. Doctors who specialize in analyzing blood and body tissue, called pathologists, will test the cells to see if they’re cancerous. Other tests in the lab show more details about the cancer cells, such as what type of cells they are. […] If your doctor thinks you might have soft tissue sarcoma, you’ll likely be referred to a cancer doctor, called an oncologist. Soft tissue sarcoma is rare and is best treated by someone who has experience with it. Doctors with this kind of experience are often found within an academic or specialized cancer center.
  • #1 Tests for Soft Tissue Sarcomas | American Cancer Society
    https://www.cancer.org/cancer/types/soft-tissue-sarcoma/detection-diagnosis-staging/how-diagnosed.html
    If you have signs or symptoms that suggest you might have a soft tissue sarcoma, the doctor will likely need to do tests to find out if you have cancer. […] If a soft tissue sarcoma is suspected based on exams and imaging tests, a biopsy is needed to know for sure that it’s a sarcoma and not another type of cancer or a benign (not cancer) disease. In a biopsy, the doctor takes out a small piece of the tumor. This tissue is looked at under a microscope and other lab tests may be done as well. […] Several types of biopsies are used to diagnose sarcomas. Doctors experienced with these tumors will choose one, based on the size and location of the tumor. Most prefer to use a fine needle aspiration or a core needle biopsy as the first step. Proper biopsy technique is a very important part of successfully treating soft tissue sarcomas. An improper biopsy can lead to tumor spread and problems removing the tumor later on.
  • #1 Diagnosing Soft Tissue Sarcoma | NYU Langone Health
    https://nyulangone.org/conditions/soft-tissue-sarcoma/diagnosis
    NYU Langone specialists are experts at diagnosing the many types of soft tissue sarcoma in adults. […] In addition to asking you about your symptoms and medical history, doctors at NYU Langone use the most up-to-date technologies and tests to detect and diagnose soft tissue sarcomas. […] Our doctors schedule an initial consultation with you within two days of your calling our center. They diagnose or confirm a diagnosis of sarcoma quickly, allowing you to start treatment within a week of your first visit. Starting treatment as soon as possible gives you the best chance of managing the sarcoma. Our doctors may recommend some of the following tests. […] A biopsy involves the removal of tissue from the body for extensive molecular and genetic laboratory tests and examination under a microscope for signs of cancer. These tests can help your doctor determine the type of soft tissue sarcoma that’s present and the therapies that may be most successful. […] Doctors may use a core needle biopsy to get a sample of a soft tissue sarcoma. […] Sometimes, diagnosing a soft tissue sarcoma using tissue from a needle biopsy can be challenging. If so, your doctor may perform a surgical biopsy in an operating room.
  • #1 Soft Tissue Sarcoma Diagnosis | MD Anderson Cancer Center
    https://www.mdanderson.org/cancer-types/soft-tissue-sarcoma/soft-tissue-sarcoma-diagnosis.html
    If at all possible, your first biopsy should be at the cancer center where you will receive treatment. Try to go to a cancer center that sees a large number of sarcoma patients and has a specialized sarcoma team that includes specialized pathologists. […] The pathologists at MD Anderson are highly specialized in diagnosing and staging every type of sarcoma. […] If you are diagnosed with sarcoma, your doctor will determine the stage (or extent) of the disease. […] Staging is a way of determining how much disease is in the body and where it has spread. This information is important because it helps your doctor determine the best type of treatment for you and the outlook for your recovery (prognosis). […] The official staging system divides sarcomas into three grades (1 to 3). The grade of a sarcoma helps predict how rapidly it will grow and spread, as well as your outlook for successful treatment (prognosis). […] Higher-grade cancers tend to grow and spread faster than lower-grade cancers.
  • #1 Soft Tissue Sarcomas | Choose the Right Test
    https://arupconsult.com/content/soft-tissue-sarcomas
    For many soft tissue sarcomas, diagnosis and classification are based on histology and supported by immunohistochemical and molecular findings. […] Immunohistochemical staining is often performed on biopsy tissue as a complement to morphologic evaluation to determine the cell/tissue type of origin and to differentiate between specific entities. […] Genetic tests on tumor samples may be useful in addition to histology and immunohistochemistry in diagnosis and classification, and may be particularly beneficial in unusual cases or when the diagnosis is not definitive. […] Fluorescence in situ hybridization (FISH) testing is used to identify common translocations that can aid in the diagnosis of soft tissue sarcomas. […] A number of inherited pathogenic variants have been associated with a risk of developing soft tissue sarcomas. […] Germline genetic testing may be recommended when patients have a personal or family history of suggestive findings, including soft tissue sarcomas, or if the histologic, immunohistochemical, or molecular features of the sarcoma suggest a possible genetic syndrome. […] Immunohistochemistry testing aids in the diagnosis and classification of soft tissue sarcomas.
  • #1 Molecular Diagnostics in Sarcoma… | College of American Pathologists
    https://www.cap.org/member-resources/articles/molecular-diagnostics-in-sarcoma-pathology
    Although malignant tumors of bone and soft tissue (i.e., sarcomas) are rare (approximately 1% of newly diagnosed cancers), they represent an outsized diagnostic challenge. This difficulty stems in part from the impressive diversity of these neoplasms which are comprised of at least 80 distinct types. Increasingly, pathologists employ molecular testing as an aid in sarcoma diagnosis. The intent of this article is to summarize the current state of routine molecular testing in sarcomas. Currently, the mainstay methods for sarcoma diagnosis are morphology and immunohistochemistry (IHC). Indeed, the most recent WHO guidelines for Bone and Soft Tissue tumors emphasize the central diagnostic importance of morphology. In practice, morphologic evaluation of sarcomas often generates a differential diagnosis for which further evaluation by ancillary methods is required. To address these limitations, molecular testing (i.e., testing DNA and/or RNA) has become increasingly common in diagnostic testing pathways for sarcomas and is often required for clinical trial protocols. Molecular diagnostic methods used for sarcomas can be grouped into several categories including targeted gene-level assays (fluorescence in situ hybridization, polymerase chain reaction), copy number arrays, and newer techniques (multiplex fluorescent color-coded probes, sequencing-based assays). Several studies have examined the utility of molecular methods in the diagnosis of sarcomas. The authors conclude that, for all sarcomas with recurrent genetic aberrations (e.g., synovial sarcoma, alveolar rhabdomyosarcoma), molecular testing should be performed. Current World Health Organization (WHO) and National Comprehensive Cancer Center (NCCN) guidelines acknowledge the utility of molecular testing in sarcoma diagnosis. Current NCCN Soft Tissue Sarcoma guidelines confirm the diagnostic utility of molecular genetic testing and recommend that such testing should be carried out by a pathologist with expertise in sarcoma diagnosis and molecular diagnostic techniques. While morphology and IHC remain the bedrock for sarcoma diagnosis, molecular methods have shown potential for improving and/or refining diagnosis of these rare tumors. Additionally, molecular genetic testing is finding greater acceptance in diagnostic guidelines for soft tissue and bone tumors. Therefore, it is expected that pathologists will increasingly be called for their expertise in the relevant molecular methods, both traditional and newer, for the sarcomas that they encounter in their clinical practice.
  • #1 Sarcoma Diagnosis | Affiliated Oncologists
    https://aocancer.com/education-resources/types-of-cancer/sarcoma/diagnosis
    If a soft tissue sarcoma is suspected, a biopsy will be done. The type of biopsy will be based on the size and location of the tumor. There are three types of biopsies commonly used. Your physician will choose the best one for you: […] The following tests may be done on the tissue that was removed: […] Immunohistochemistry study: is used to tell the difference between different types of cancer. […] Light and electron microscopy: Used to look for certain changes in the cells. […] Cytogenetic analysis: Used to look for certain changes in the chromosomes. […] FISH (fluorescence in situ hybridization): A laboratory test used to look at genes or chromosomes in cells and tissues. […] Flow cytometry: A laboratory test that measures the number of cells in a sample, the percentage of live cells in a sample, and certain characteristics of cells, such as size, shape, and the presence of tumor markers on the cell surface.
  • #1 Sarcoma Diagnosis – Virginia Oncology
    https://www.virginiacancer.com/sarcoma/diagnosis/
    If a soft tissue sarcoma is suspected, a biopsy will be done. The type of biopsy will be based on the size and location of the tumor. […] The following tests may be done on the tissue that was removed: […] Cytogenetic analysis: Used to look for certain changes in the chromosomes. […] FISH (fluorescence in situ hybridization): A laboratory test used to look at genes or chromosomes in cells and tissues. […] Flow cytometry: A laboratory test that measures the number of cells in a sample, the percentage of live cells in a sample, and certain characteristics of cells, such as size, shape, and the presence of tumor markers on the cell surface. […] Immunohistochemistry study: is used to tell the difference between different types of cancer. […] Light and electron microscopy: Used to look for certain changes in the cells.
  • #1 Soft Tissue Sarcoma Diagnosis | Memorial Sloan Kettering Cancer Center
    https://www.mskcc.org/cancer-care/types/soft-tissue-sarcoma/diagnosis
    In fact, when our pathologists are asked for a second opinion about soft tissue sarcoma, we change the diagnosis about 15 percent of the time. […] We use genetic and molecular sequencing on the tumors of nearly all our patients with soft tissue sarcoma. By making absolutely sure that we have diagnosed the correct sarcoma type, we can better determine the most effective treatment approach. […] Staging soft tissue sarcoma involves identifying the location of the tumor and how far it may have spread. Once the tumor is staged, we can design a personalized treatment strategy for you.
  • #1 Sarcoma Diagnosis And Classification | Genomic Testing Cooperative
    https://genomictestingcooperative.com/sarcoma-diagnosis-and-classification/
    Sarcoma Diagnosis and Classification. The GTC Solid Tumor Expression/Fusion Profiling provides highly informative and actionable data for patients with sarcoma. […] Sarcomas are heterogeneous group of cancer that arises in the connective tissue. Diagnosis and subclassification of sarcoma can be very difficult due to overlapping in histological and immunohistological features. Determining the molecular abnormalities, especially fusion genes and chromosomal translocations in a specific sarcoma can be very helpful in diagnosis, subclassification and determining therapy. […] In general, the presence of a specific translocation in one sarcoma type does not occur in any other types of sarcoma, thus it is very helpful to test for the driver abnormality in subclassification of sarcomas. Using NGS is the most comprehensive and cost-effective approach to determine the driver molecular abnormality in a cancer expected to be a sarcoma. Our NGS assay analyzes the most common genes involved in translocations reported in sarcoma and covers all partner genes in a fashion similar to break apart probes in FISH testing. […] Additional translocations can also be detected with our assay. In addition, mutations in various genes can also be detected and will be reported.
  • #1 Soft Tissue Sarcomas | Choose the Right Test
    https://arupconsult.com/content/soft-tissue-sarcomas
    Sarcomas are rare tumors that can arise from a variety of nonepithelial tissues, including soft tissues such as blood vessels, fat, muscles, and nerves. Correct identification of the specific type of tumor is important to ensure appropriate treatment and determine prognosis. […] Although morphology is the basis for diagnosis, laboratory testing, including immunohistochemistry, cytogenetics, and molecular genetics, may play an essential role in diagnosis and classification. Germline genetic testing may also be used in the evaluation of genetic syndromes associated with soft tissue sarcomas. […] Molecular genetic testing may be useful to support the diagnosis and classification of soft tissue sarcomas. Many soft tissue sarcoma subtypes exhibit cytogenetic and molecular abnormalities, including amplifications, deletions, recurrent translocations, or single base-pair substitutions. […] Laboratory testing for soft tissue sarcomas is appropriate in individuals with a biopsy specimen that is suspicious for sarcoma and requires additional information beyond what can be provided by a morphologic evaluation.
  • #1 Diagnosing Bone Cancer and Soft Tissue Sarcoma | Bone and Musculoskeletal Cancer | Henry Ford Health – Detroit, MI
    https://www.henryford.com/services/bone-cancer/diagnosis
    Once we diagnose cancer, your doctor explains your treatment options and works with you to create a personalized treatment plan. […] Your doctor may recommend genetic testing if your family history includes certain cancers or inherited conditions. […] We may recommend genetic testing for bone cancer if you have a family history of one of these conditions: Li-Fraumeni syndrome, Hereditary retinoblastoma, Rothmund-Thompson syndrome. […] A family history of certain inherited conditions can put you at higher risk for soft tissue sarcomas. Genetic testing can detect the genes that cause these conditions: Neurofibromatosis, Gardner syndrome, Li-Fraumeni syndrome, Retinoblastoma, Werner syndrome, Gorlin syndrome, Tuberous sclerosis.
  • #1 Causes and Diagnosis of Sarcoma | Northwestern Medicine
    https://www.nm.org/conditions-and-care-areas/cancer-care/sarcoma-program/sarcoma/causes-and-diagnoses
    Your care team needs a tumor sample from a biopsy or a surgery to determine if you have a sarcoma. […] Getting an accurate diagnosis is important because it helps your care team make an effective treatment plan. Because sarcomas are so rare, many physicians are not familiar with them. To get an accurate diagnosis, find a specially trained expert with experience in treating sarcoma. […] Choose a hospital with a pathologist who has experience with sarcomas to help ensure you get an accurate diagnosis. […] Imaging studies are very important for diagnosing sarcoma. They help your care team learn how advanced the cancer is and develop a treatment plan.
  • #1 Soft Tissue Sarcoma Diagnosis | MD Anderson Cancer Center
    https://www.mdanderson.org/cancer-types/soft-tissue-sarcoma/soft-tissue-sarcoma-diagnosis.html
    MD Andersons team of specialized surgeons and pathologists is one of the most experienced and skilled in the nation in diagnosing sarcomas. […] We have the latest methods and technology to be sure you get the most accurate diagnosis possible. This can make a difference in the success of your treatment. […] The only way to be certain a tumor is soft tissue sarcoma is a biopsy (removing a small number of cells to examine under a microscope). Imaging tests may be used before or after biopsy to determine the location and extent of the tumor. […] Since sarcomas are complex and can develop in so many places in the body, they can be difficult to diagnose. However, its important to have an accurate diagnosis of the type and extent of the sarcoma before you are treated. […] Getting the wrong diagnosis may actually be harmful and make therapy have less chance for success. A biopsy that is not done correctly can cause the cancer to spread and make your treatment more difficult. It is best for the surgeon who does the biopsy to also remove the tumor.
  • #1 Diagnosis & Treatment – Sarcoma | Cancer Services | University Hospitals | Cleveland, OH | University Hospitals
    https://www.uhhospitals.org/services/cancer-services/sarcoma/sarcoma-diagnosis-and-treatment
    The diagnosis of sarcoma can be challenging and requires a skilled interventional radiologist and an experienced sarcoma pathologist. A number of modalities are needed not only to diagnose sarcoma but also to identify the correct subtype. […] A sarcoma diagnosis usually involves: A medical history and a physical exam performed by a sarcoma specialist, Imaging studies, such as X-rays, computed tomography (CT), ultrasound, magnetic resonance imaging (MRI), or PET scans: Our state-of-the-art imaging equipment provides clear and precise imaging that guides our experts to identify the exact location and extent of cancer. […] A biopsy involves a minor procedure where a needle is inserted into the tumor body to obtain a tissue sample, which is then examined in the lab. Our team of musculoskeletal radiologists performs an imaging-guided biopsy, which is examined by our experienced sarcoma-pathologists. […] At University Hospitals, we have dedicated team musculoskeletal radiologists and interventional radiologists who have the necessary expertise in obtaining tissue samples, which are then examined by our experienced sarcoma pathologists.
  • #1 Patients’ Experiences of a Sarcoma Diagnosis: A Process Mapping Exercise of Diagnostic Pathways
    https://www.mdpi.com/2072-6694/15/15/3946
    Patients with sarcoma often report prolonged time to diagnosis, which is attributed to the rarity of sarcoma and the low awareness of pre-diagnostic signs and symptoms. […] The pathway from symptom onset to diagnosis is complex but recognised to be divided into distinct phases: the patient interval and the diagnostic interval. […] The National Institute for Health and Care Excellence (NICE) recommends that adults with symptoms suggestive of sarcoma should be referred to specialists for further assessment within 2 weeks. […] However, the heterogeneity and ambiguity of symptoms that may be indicative of sarcoma often result in patients experiencing longer times to referral for specialist tests and diagnosis compared with more common cancers. […] Prolonged times to diagnosis in rare cancers such as sarcoma can be attributed to the frequency with which healthcare professionals encounter a rare cancer diagnosis and less research detailing symptom profiles.
  • #1 Patients’ Experiences of a Sarcoma Diagnosis: A Process Mapping Exercise of Diagnostic Pathways
    https://www.mdpi.com/2072-6694/15/15/3946
    Sarcoma patients are more likely to report multiple GP visits and be dissatisfied with the time taken to see a hospital doctor compared with those with common cancers whose symptoms are more defined. […] Early diagnosis of cancer is likely to improve patient experience and health-related quality of life (HRQoL), whilst prolonged time to diagnosis can lead to adverse clinical outcomes. […] Prolonged times to diagnosis were experienced by the majority of patients in our sample. […] Further research into the evolution of pre-diagnostic sarcoma symptoms is required to inform awareness interventions. […] The characteristics of the diagnostic pathway differed between sarcoma types, similar to other reports. […] Misdiagnosis occurred due to symptoms being attributed to active lifestyles, for example, participating in activities such as squash and kickboxing.
  • #1 How to understand and face a sarcoma diagnosis | Sarah Cannon
    https://sarahcannon.com/blog/entry/how-to-understand-and-face-a-sarcoma-diagnosis
    Cancer can be overwhelming. At Sarah Cannon, we are sensitive to the newness of medical terms, treatment recommendations, and appointment schedules. To help ease fear and anxiety, we empower and equip patients and caregivers with the information and support they need throughout their cancer journey. If you or a loved one has received a sarcoma diagnosis, we hope this overview will serve as a resource that brings clarity and comfort. […] Sarcoma is often difficult to detect and may sometimes even be misdiagnosed. Consistent pain in the bones, swelling of joints, or abdominal pain are often overlooked signs of sarcoma, especially in young people who experience these symptoms as „growing pains.” […] Traditional treatment options for sarcomas include surgery, radiation therapy, chemotherapy, and immunotherapy. Your care team will determine a treatment plan specific to your cancer, which may include a clinical trial.
  • #1 Sarcoma – Diagnosis & Treatment : Emergency Care BC
    https://emergencycarebc.ca/clinical_resource/clinical-summary/sarcoma-diagnosis-treatment/
    Sarcoma – Diagnosis & Treatment […] Sarcoma is a broad group of malignancies (there are over 50 histological types) that generally arise de novo from mesenchymal originated tissues (i.e., soft tissue and bone). However in older patients they can arise secondarily in some instances. […] Clinical starting point is considering sarcoma in the differential based on history and physical findings. […] Clinical end point is contacting oncology if findings on history, physical exam and imaging are suspicious in order to organize diagnostic biopsy, staging and treatment promptly if appropriate. […] Plain film imaging first diagnostic test if suspicion raised. […] If suspicious findings on imaging involve oncology immediately in order to arrange for appropriate CT/MRI to determine extent and size as well as diagnostic biopsy which will then guide treatment. […] Sarcoma treatments differ substantially depending on histological type. […] Sarcoma is rare. It must be treated by specialist that is familiar with current protocols. […] Treatment generally involves surgical resection and adjuvant therapy.
  • #1 Issues in sarcoma diagnosis | Sarcoma UK
    https://sarcoma.org.uk/issues-in-diagnosis/
    Delays in diagnosis are also associated with increased risk of metastases, increased risk of amputation rather than limb salvage surgery and may have an impact on a patients opportunity for fertility preservation. […] Patients regularly tell us that their symptoms are often dismissed by primary healthcare professionals, such as GPs. […] Sarcomas are often missed on scans, either due to machines being misused or scans being misreported. This often means patients with sarcoma are incorrectly told that they dont have cancer and are consequently diagnosed at a later stage, and less likely to be cured. […] Despite 15 people in the UK being diagnosed with sarcoma every day, only 25% of the population know what sarcoma is, with even fewer people recognising its signs and symptoms. […] This leads those with sarcoma not to recognise their symptoms as being potentially a cancer, and they book an appointment with the GP.
  • #1 Sarcoma Diagnosis and Staging | Sarah Cannon
    https://sarahcannon.com/for-patients/learn-about-cancer/sarcoma/staging.dot
    Sarcoma Diagnosis and Staging […] To make an accurate diagnosis, your doctor may use one or more tests to check for cancer. Before testing, your physician will consider: […] Usually, the first step in diagnosing sarcoma is an imaging test. Imaging can detect both noncancerous and cancerous tumors. Diagnosing sarcoma can be challenging, so it’s important to see a physician who has experience diagnosing and treating sarcoma. […] If imaging tests show that you have a tumor, your doctor will likely recommend a biopsy. A biopsy is used to confirm a diagnosis. During a biopsy, a physician will remove a small amount of tissue from the affected part of your body. […] After a biopsy, the tissue sample is sent to a pathologist (a medical doctor who interprets laboratory tests) for evaluation. The pathologist will look at the tissue sample under a microscope to determine if the tumor’s cells are cancerous or benign. […] Cancer staging is used to describe where the cancer began, if it has spread, where it has spread and if it’s affecting other areas of the body. The stage of the sarcoma will inform what type of treatment you may need. […] Doctors use the TNM method to stage many types of cancer, including sarcoma. […] The answers to these questions will determine the sarcoma’s stage (I through IV, or 1 through 4). […] Next, your physician will assess the cancer’s grade (G). The grade describes how much cancer cells resemble healthy cells under a microscope. […] Your physician will combine the results of your TNM and G classifications to determine the cancer’s stage. Staging will vary based on where the sarcoma began.
  • #1 Issues in sarcoma diagnosis | Sarcoma UK
    https://sarcoma.org.uk/issues-in-diagnosis/
    Being diagnosed with any cancer is an isolating and lonely experience. […] This is particularly true for sarcoma patients, who have agonisingly long waits for a diagnosis of a cancer that has such limited treatment options. […] The later that any cancer, including sarcoma, is diagnosed, there will be even fewer options available for treatment and a higher chance of treatments not working. Put simply, late diagnosis costs lives. […] For soft tissue sarcomas, survival is determined be tumour size, grade and location. The only one of these factors that can be altered to improve outcome is the size of the tumour at diagnosis. By early detection we can catch tumours at a smaller size and improve outcomes. […] Catching sarcoma at an early stage also means that the cancer is less likely to have spread, increasing the chance of survival.
  • #1 The complexity of diagnosing sarcoma in a timely manner: perspectives of health professionals, patients, and carers in Australia | BMC Health Services Research | Full Text
    https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-020-05532-8
    Delays in diagnosis are associated with larger tumours, increased risk of metastases, and increased risk of amputation rather than limb salvage surgery. […] Sarcoma can be challenging to diagnose compared to other cancers due to its heterogeneous nature and rarity. […] Increased intervals also occur when health professionals provide incorrect diagnoses and refer patients for unnecessary tests. […] Sarcoma patients frequently have multiple GP consultations, with bone sarcoma having amongst the highest rates of GP consultations amongst rare cancers. […] Although sources of delay have been reported internationally, there is a need to explore the sources of delay in the local context. […] The aim of this study was to explore patients, carers, and health professionals perceived barriers to timely diagnosis and referral for treatment for sarcoma.
  • #1 The complexity of diagnosing sarcoma in a timely manner: perspectives of health professionals, patients, and carers in Australia | BMC Health Services Research | Full Text
    https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-020-05532-8
    Prolonged diagnosis intervals occur more often in rare cancers, such as sarcoma. Patients with a delayed diagnosis may require more radical surgery and have a reduced chance of survival. […] The aim of this study was to explore patients, carers, and health professionals perceived barriers to timely diagnosis and referral for treatment for sarcoma. […] Diagnosis was prolonged by the limited availability of health services, lack of prompt referrals to a sarcoma specialist centre, and diagnostic challenges. […] Patients with a potential sarcoma need to be promptly referred to a sarcoma specialist centre and additional diagnosis pathways need to be developed to reduce the rate of patients being referred to wrong specialists. […] A systematic review concluded that, for commonly occurring cancers, expedited diagnosis improves cancer outcomes. For sarcoma patients, early diagnosis is essential to reduce the magnitude of surgery and increase survival chances.
  • #1 Sarcoma Diagnostic Process | Stanford Health Care
    https://stanfordhealthcare.org/medical-conditions/cancer/sarcoma/patient-care-resources/diagnosis.html
    This overview explains what to expect as you go through diagnosis. […] An accurate diagnosis is critical for your treatment plan. It helps us recommend the most effective treatment options for you, in the right sequence. […] For everyone who comes to us, we start your care by confirming a diagnosis. […] Our team meets with you for a thorough diagnostic evaluation. We gather more information during your first appointment but may still need additional tests to confirm or rule out a diagnosis. […] After this testing, it typically takes a few days to 2 weeks to review the results and confirm your diagnosis. Getting your test results can take time because your care team is working hard to determine an accurate diagnosis for you. […] Your care team will also determine the stage of your cancer. Staging describes the size of the cancer and whether (and how far) it has spread. Staging is the most important step in planning your treatment.
  • #1 Clinical practice guidelines for the diagnosis and treatment of patients with soft tissue sarcoma by the Spanish group for research in sarcomas (GEIS)
    https://pmc.ncbi.nlm.nih.gov/articles/PMC4706580/
    Surgery is the mainstay of treatment in localized STS. […] Surgical treatment should be performed by expert surgeons and should be based on consensus decisions taken on a multidisciplinary board. […] Adjuvant radiotherapy (RT) is offered in addition to conservative surgery to optimize local control. […] The conclusions of this study are pertinent only to patients who undergo a satisfactory local excision with negative or minimal microscopically positive resection margins. […] The use of adjuvant chemotherapy has been studied in several clinical trials because of the risk of metastasis which is close to 50 % in the group of patients with high-risk STS. […] Consequently, data from meta-analysis indicate that adjuvant chemotherapy using anthracycline-based regimens provides a significant, although limited, improvement in relapse and survival in patients with high-risk STS.
  • #2 Sarcoma: What it Is, Symptoms & Treatment
    https://my.clevelandclinic.org/health/diseases/17934-sarcoma
    They may use any of the following tests when making a diagnosis: X-ray, Computed tomography (CT) scan, Magnetic resonance imaging (MRI), Bone scan, PET scan, Biopsy. […] Cancer staging is used to better understand how serious a sarcoma is and what treatments may work best. Providers classify most sarcoma based on the TNM classification system. […] Your treatment will depend on various factors, including the type of sarcoma, its size and location, your general health, whether the sarcoma is newly diagnosed or returned (recurrent). […] The five-year survival rate of soft tissue sarcoma ranges from 15% for metastasized cancer (cancer that has spread to other parts of your body) to 81% for cancer that hasnt spread. The five-year survival rate for osteosarcoma (the most common type of bone cancer) ranges from 26% for metastasized cancer to 77% for cancer that hasnt spread. […] If youre diagnosed with sarcoma, consider that your treatment options and prognosis depend on multiple factors your healthcare provider can explain to you. Treatment options and likely outcomes are as varied as sarcomas are.
  • #2 Soft tissue sarcoma: Recognizing a rare disease | Cleveland Clinic Journal of Medicine
    https://www.ccjm.org/content/89/2/73
    The recognition of a malignant soft tissue mass can be challenging, given the rarity of soft tissue sarcoma and the extensive overlap between benign and malignant presentations. […] Awareness of the signs and symptoms of soft tissue sarcoma in primary care practice ensures prompt referral to a sarcoma center for appropriate assessment and treatment to optimize outcomes. […] The rarity of soft tissue sarcoma, its heterogeneity, and overlap of symptoms with benign conditions are challenges to timely diagnosis. […] Patients suspected of having a soft tissue sarcoma require prompt referral to a sarcoma center for assessment and treatment. […] Early recognition of the signs and symptoms of soft tissue sarcoma (STS) and prompt referral to a center with expertise in STS are essential to ensure effective multidisciplinary team management and optimize outcome.
  • #2 Diagnosis and treatment of soft-tissue sarcomas of the extremities and trunk
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5702952/
    Pain assessment is important in every physician-patient consultation. In cases of STS, however, pain is a rather poor discriminator between benign and malignant lesions. […] As the majority of STSs are located deep to the fascia, every deeply-situated tumour should be considered malignant until proven otherwise. […] A simple rule of thumb is that every growing soft-tissue mass larger than a golf ball (equivalent to about 4 cm) that has been recently noticed should be suspected of being a sarcoma. […] The chief objectives of imaging are to confirm clinical findings by detecting a soft-tissue mass, to estimate its size, tissue quality and relation to adjacent structures in detail, and to aid planning of the further course of action. […] Magnetic resonance imaging (MRI) is the method of choice to evaluate soft-tissue tumours and to distinguish benign from malignant lesions, especially if prior clinical findings and imaging were inconclusive.
  • #2 Diagnosis of soft tissue sarcoma | Canadian Cancer Society
    https://cancer.ca/en/cancer-information/cancer-types/soft-tissue-sarcoma/diagnosis
    A complete blood count (CBC) measures the number and quality of white blood cells, red blood cells and platelets. A CBC is done to check your general health, often before a biopsy. […] Blood clotting (coagulation) tests check if your blood is clotting properly. Prothrombin time (PT), partial thromboplastin time (PTT) and international normalized ratio (INR) are common blood clotting tests. They are usually checked before a biopsy is done. […] An MRI is commonly used to examine a lump that doctors think may be a soft tissue sarcoma. It is often the first imaging test done for lumps in the arms or legs. An MRI can check the size of a tumour, what tissues and areas are nearby and if it has spread to other parts of the body. […] A CT scan is commonly used to examine a lump in a specific area, including checking its size and finding out what tissues and areas are nearby. It is often used to check the abdomen, back of the abdomen (retroperitoneum) and chest. If soft tissue sarcoma is diagnosed, a CT scan can be used to check if the cancer has spread to other parts of the body.
  • #2 Soft Tissue Sarcoma Diagnosis and Detection
    https://www.cancercenter.com/cancer-types/soft-tissue-sarcoma/diagnosis-and-detection
    PET scans are very sensitive but don’t show much detail, they often are performed in combination with a CT scan (called PET/CT). […] Ultrasound scans may be used to provide information about a tumor or surrounding tissues and organs, and to precisely locate the position of a tumor in order to guide a needle biopsy. […] The lungs are a common location for soft tissue sarcomas to metastasize (spread). Therefore, X-rays of the chest may be taken to see if the cancer has spread to the lungs. […] Laparoscopic ultrasound and laparoscopic biopsies may also be performed by the surgeon to diagnose and stage soft tissue sarcoma. For tumors located within the abdomen, a laparoscopic procedure is sometimes used to diagnose or stage the extent of disease.
  • #2 Tests for Soft Tissue Sarcomas | American Cancer Society
    https://www.cancer.org/cancer/types/soft-tissue-sarcoma/detection-diagnosis-staging/how-diagnosed.html
    If you have signs or symptoms that suggest you might have a soft tissue sarcoma, the doctor will likely need to do tests to find out if you have cancer. […] If a soft tissue sarcoma is suspected based on exams and imaging tests, a biopsy is needed to know for sure that it’s a sarcoma and not another type of cancer or a benign (not cancer) disease. In a biopsy, the doctor takes out a small piece of the tumor. This tissue is looked at under a microscope and other lab tests may be done as well. […] Several types of biopsies are used to diagnose sarcomas. Doctors experienced with these tumors will choose one, based on the size and location of the tumor. Most prefer to use a fine needle aspiration or a core needle biopsy as the first step. Proper biopsy technique is a very important part of successfully treating soft tissue sarcomas. An improper biopsy can lead to tumor spread and problems removing the tumor later on.
  • #2 What is Sarcoma? – SFA
    https://curesarcoma.org/sarcoma-education/what-is-sarcoma/
    A pathologist examines the tissue and lab tests can determine whether the cells are cancerous and what sarcoma subtype they represent. If cancer is present, the pathologist can usually determine the type of cancer and its grade. The grade of the tumor is determined by how abnormal the cancer cells appear when examined under a microscope. […] Low-grade sarcomas, although cancerous, are unlikely to spread to other parts of the body (metastasize). High-grade sarcomas are more likely to spread metastasize.
  • #2 Soft Tissue Sarcomas | Choose the Right Test
    https://arupconsult.com/content/soft-tissue-sarcomas
    For many soft tissue sarcomas, diagnosis and classification are based on histology and supported by immunohistochemical and molecular findings. […] Immunohistochemical staining is often performed on biopsy tissue as a complement to morphologic evaluation to determine the cell/tissue type of origin and to differentiate between specific entities. […] Genetic tests on tumor samples may be useful in addition to histology and immunohistochemistry in diagnosis and classification, and may be particularly beneficial in unusual cases or when the diagnosis is not definitive. […] Fluorescence in situ hybridization (FISH) testing is used to identify common translocations that can aid in the diagnosis of soft tissue sarcomas. […] A number of inherited pathogenic variants have been associated with a risk of developing soft tissue sarcomas. […] Germline genetic testing may be recommended when patients have a personal or family history of suggestive findings, including soft tissue sarcomas, or if the histologic, immunohistochemical, or molecular features of the sarcoma suggest a possible genetic syndrome. […] Immunohistochemistry testing aids in the diagnosis and classification of soft tissue sarcomas.
  • #2 Soft Tissue Sarcoma Diagnosis | MD Anderson Cancer Center
    https://www.mdanderson.org/cancer-types/soft-tissue-sarcoma/soft-tissue-sarcoma-diagnosis.html
    MD Andersons team of specialized surgeons and pathologists is one of the most experienced and skilled in the nation in diagnosing sarcomas. […] We have the latest methods and technology to be sure you get the most accurate diagnosis possible. This can make a difference in the success of your treatment. […] The only way to be certain a tumor is soft tissue sarcoma is a biopsy (removing a small number of cells to examine under a microscope). Imaging tests may be used before or after biopsy to determine the location and extent of the tumor. […] Since sarcomas are complex and can develop in so many places in the body, they can be difficult to diagnose. However, its important to have an accurate diagnosis of the type and extent of the sarcoma before you are treated. […] Getting the wrong diagnosis may actually be harmful and make therapy have less chance for success. A biopsy that is not done correctly can cause the cancer to spread and make your treatment more difficult. It is best for the surgeon who does the biopsy to also remove the tumor.
  • #2 Soft Tissue Sarcoma Diagnosis | MD Anderson Cancer Center
    https://www.mdanderson.org/cancer-types/soft-tissue-sarcoma/soft-tissue-sarcoma-diagnosis.html
    If at all possible, your first biopsy should be at the cancer center where you will receive treatment. Try to go to a cancer center that sees a large number of sarcoma patients and has a specialized sarcoma team that includes specialized pathologists. […] The pathologists at MD Anderson are highly specialized in diagnosing and staging every type of sarcoma. […] If you are diagnosed with sarcoma, your doctor will determine the stage (or extent) of the disease. […] Staging is a way of determining how much disease is in the body and where it has spread. This information is important because it helps your doctor determine the best type of treatment for you and the outlook for your recovery (prognosis). […] The official staging system divides sarcomas into three grades (1 to 3). The grade of a sarcoma helps predict how rapidly it will grow and spread, as well as your outlook for successful treatment (prognosis). […] Higher-grade cancers tend to grow and spread faster than lower-grade cancers.
  • #2 Soft Tissue Sarcoma Diagnosis | Memorial Sloan Kettering Cancer Center
    https://www.mskcc.org/cancer-care/types/soft-tissue-sarcoma/diagnosis
    In fact, when our pathologists are asked for a second opinion about soft tissue sarcoma, we change the diagnosis about 15 percent of the time. […] We use genetic and molecular sequencing on the tumors of nearly all our patients with soft tissue sarcoma. By making absolutely sure that we have diagnosed the correct sarcoma type, we can better determine the most effective treatment approach. […] Staging soft tissue sarcoma involves identifying the location of the tumor and how far it may have spread. Once the tumor is staged, we can design a personalized treatment strategy for you.
  • #2 Issues in sarcoma diagnosis | Sarcoma UK
    https://sarcoma.org.uk/issues-in-diagnosis/
    Being diagnosed with any cancer is an isolating and lonely experience. […] This is particularly true for sarcoma patients, who have agonisingly long waits for a diagnosis of a cancer that has such limited treatment options. […] The later that any cancer, including sarcoma, is diagnosed, there will be even fewer options available for treatment and a higher chance of treatments not working. Put simply, late diagnosis costs lives. […] For soft tissue sarcomas, survival is determined be tumour size, grade and location. The only one of these factors that can be altered to improve outcome is the size of the tumour at diagnosis. By early detection we can catch tumours at a smaller size and improve outcomes. […] Catching sarcoma at an early stage also means that the cancer is less likely to have spread, increasing the chance of survival.
  • #2 The complexity of diagnosing sarcoma in a timely manner: perspectives of health professionals, patients, and carers in Australia | BMC Health Services Research | Full Text
    https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-020-05532-8
    Prolonged diagnosis intervals occur more often in rare cancers, such as sarcoma. Patients with a delayed diagnosis may require more radical surgery and have a reduced chance of survival. […] The aim of this study was to explore patients, carers, and health professionals perceived barriers to timely diagnosis and referral for treatment for sarcoma. […] Diagnosis was prolonged by the limited availability of health services, lack of prompt referrals to a sarcoma specialist centre, and diagnostic challenges. […] Patients with a potential sarcoma need to be promptly referred to a sarcoma specialist centre and additional diagnosis pathways need to be developed to reduce the rate of patients being referred to wrong specialists. […] A systematic review concluded that, for commonly occurring cancers, expedited diagnosis improves cancer outcomes. For sarcoma patients, early diagnosis is essential to reduce the magnitude of surgery and increase survival chances.
  • #2 Sarcoma Diagnosis and Staging | Sarah Cannon
    https://sarahcannon.com/for-patients/learn-about-cancer/sarcoma/staging.dot
    Sarcoma Diagnosis and Staging […] To make an accurate diagnosis, your doctor may use one or more tests to check for cancer. Before testing, your physician will consider: […] Usually, the first step in diagnosing sarcoma is an imaging test. Imaging can detect both noncancerous and cancerous tumors. Diagnosing sarcoma can be challenging, so it’s important to see a physician who has experience diagnosing and treating sarcoma. […] If imaging tests show that you have a tumor, your doctor will likely recommend a biopsy. A biopsy is used to confirm a diagnosis. During a biopsy, a physician will remove a small amount of tissue from the affected part of your body. […] After a biopsy, the tissue sample is sent to a pathologist (a medical doctor who interprets laboratory tests) for evaluation. The pathologist will look at the tissue sample under a microscope to determine if the tumor’s cells are cancerous or benign. […] Cancer staging is used to describe where the cancer began, if it has spread, where it has spread and if it’s affecting other areas of the body. The stage of the sarcoma will inform what type of treatment you may need. […] Doctors use the TNM method to stage many types of cancer, including sarcoma. […] The answers to these questions will determine the sarcoma’s stage (I through IV, or 1 through 4). […] Next, your physician will assess the cancer’s grade (G). The grade describes how much cancer cells resemble healthy cells under a microscope. […] Your physician will combine the results of your TNM and G classifications to determine the cancer’s stage. Staging will vary based on where the sarcoma began.
  • #2 Clinical practice guidelines for the diagnosis and treatment of patients with soft tissue sarcoma by the Spanish group for research in sarcomas (GEIS)
    https://pmc.ncbi.nlm.nih.gov/articles/PMC4706580/
    The number of studies regarding neoadjuvant chemotherapy in STS is limited, and most of them are small series and phase II trials. […] In those cases, probably the combination of pre-operative radiation and chemotherapy might have advantages over either modality alone. […] Hyperthermic isolated limb perfusion (ILP) is a therapeutic approach that can be planned in STS when optimal conservative surgical procedure is not feasible, either due to tumour or patient comorbidity. […] Therefore, hyperthermic ILP with TNF- and melphalan constitutes an option. […] Patients with exclusive pulmonary metastasis should be evaluated for surgery. […] The decision of metastasectomy should be based on disease-free period following primary surgery (ideally greater than one year) and total number of lesions.